Latest House Energy And Commerce Committee Hearing on 340B Drug Pricing Program Focuses On HRSA Oversight Concerns And Proposed Legislation

The House Energy & Commerce Committee’s Health Subcommittee has held a hearing titled, “Opportunities to Improve the 340B Drug Pricing Program"

By William Clarkson & Jessica Rennert | King & Spalding on July 24, 2018 at 3:00 PM

Shares56